ar INM-089 IVT formulation selected for continued developmentDemonstrated successful delivery at doses up to 10 times the projected therapeutic level, indicating a favorable pharmacokinetic ...

Fintel reports that on March 20, 2025, Wolfe Research initiated coverage of InvenTrust Properties (NYSE:IVT) with a Peer Perform recommendation. As of March 19, 2025, the average one-year price ...

Following the COVID-19 pandemic, mRNA-based vaccines have been shown to provide rapid and precise immune responses, however, this technology has much wider applications. Many leading pharma and ...

Verified Market Research®, a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the RNA Therapeutics ...

Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT. Ocular Therapeutix's Financial Performance Market Capitalization Analysis: Falling below industry benchmarks, the company's ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

Ninetails, a neural network that uses Nanopore Direct RNA sequencing data to identify non-A residues in mRNA poly(A) tails is presented. Particularly non-A of therapeutic, mitochondrial ...

The Hyundai Verna is a compact sedan which is known for its futuristic and unconventional design language, which can be a hit or a miss. The Verna comes loaded with all the features one would ...